AMN
Clinical trials for AMN explained in plain language.
Never miss a new study
Get alerted when new AMN trials appear
Sign up with your email to follow new studies for AMN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy trial for rare nerve disease halted early
Disease control TerminatedThis study tested a one-time gene therapy (SBT101) given into the spinal fluid to treat adrenomyeloneuropathy (AMN), a rare inherited nerve disease that causes walking problems. The trial enrolled 8 adults aged 18-65 and was terminated early. The goal was to check safety and whet…
Matched conditions: AMN
Phase: PHASE1, PHASE2 • Sponsor: SwanBio Therapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New study aims to map rare nerve disease progression
Knowledge-focused TerminatedThis study looked at how walking ability and quality of life change over time in adults with a rare inherited nerve disease called AMN (a form of spastic paraplegia). Researchers followed 65 men aged 18 and older who had spinal cord symptoms. The goal was to better understand the…
Matched conditions: AMN
Sponsor: SwanBio Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC